Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hitoshi Ishikawa

Showing results (251-260 of 404) with videos related to

Pageof 41
Sort By:
International Journal of Radiation Oncology, Biology, Physics|October 16, 2002
Correlations between in vivo tumor weight, oxygen pressure, 31P NMR spectroscopy, hypoxic microenvironment marking by beta-D-iodinated azomycin galactopyranoside (beta-D-IAZGP), and radiation sensitivityJun-Ichi Saitoh, Hideyuki Sakurai, Yoshiyuki Suzuki, et al.
Practical Radiation Oncology|November 22, 2014
Long-term survival after treatment of glioblastoma multiforme with hyperfractionated concomitant boost proton beam therapyMasashi Mizumoto, Tetsuya Yamamoto, Shingo Takano, et al.
Biomedical Optics Express|January 25, 2011
Full-range imaging of eye accommodation by high-speed long-depth range optical frequency domain imagingHiroyuki Furukawa, Hideaki Hiro-Oka, Nobuyuki Satoh, et al.
Anticancer Research|November 4, 2021
Hypofractionated Proton Beam Therapy for cT1-2N0M0 Non-small Cell Lung Cancer Patients With Interstitial Lung DiseaseTakashi Saito, Kayoko Ohnishi, Hitoshi Ishikawa, et al.
International Journal of Radiation Oncology, Biology, Physics|September 19, 2006
Risk factors of late rectal bleeding after carbon ion therapy for prostate cancerHitoshi Ishikawa, Hiroshi Tsuji, Tadashi Kamada, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 25, 2019
Concurrent chemoradiotherapy using proton beams for unresectable locally advanced pancreatic cancerYuichi Hiroshima, Nobuyoshi Fukumitsu, Takashi Saito, et al.
Cancer Biology & Therapy|June 22, 2007
The radiation-induced cell-death signaling pathway is activated by concurrent use of cisplatin in sequential biopsy specimens from patients with cervical cancerMayumi Iwakawa, Tatsuya Ohno, Kaori Imadome, et al.
Japanese Journal of Radiology|July 8, 2018
Normal liver tissue change after proton beam therapyNobuyoshi Fukumitsu, Shinsei Takahashi, Toshiyuki Okumura, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 15, 2006
Carbon ion radiation therapy for prostate cancer: results of a prospective phase II studyHitoshi Ishikawa, Hiroshi Tsuji, Tadashi Kamada, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|June 13, 2022
Carbon-ion radiotherapy for urological cancersHitoshi Ishikawa, Yuichi Hiroshima, Nobuyuki Kanematsu, et al.
Pageof 41

Showing results (251-260 of 404) with videos related to

Sort By:
Pageof 41
International Journal of Radiation Oncology, Biology, Physics|October 16, 2002
Correlations between in vivo tumor weight, oxygen pressure, 31P NMR spectroscopy, hypoxic microenvironment marking by beta-D-iodinated azomycin galactopyranoside (beta-D-IAZGP), and radiation sensitivityJun-Ichi Saitoh, Hideyuki Sakurai, Yoshiyuki Suzuki, et al.
Practical Radiation Oncology|November 22, 2014
Long-term survival after treatment of glioblastoma multiforme with hyperfractionated concomitant boost proton beam therapyMasashi Mizumoto, Tetsuya Yamamoto, Shingo Takano, et al.
Biomedical Optics Express|January 25, 2011
Full-range imaging of eye accommodation by high-speed long-depth range optical frequency domain imagingHiroyuki Furukawa, Hideaki Hiro-Oka, Nobuyuki Satoh, et al.
Anticancer Research|November 4, 2021
Hypofractionated Proton Beam Therapy for cT1-2N0M0 Non-small Cell Lung Cancer Patients With Interstitial Lung DiseaseTakashi Saito, Kayoko Ohnishi, Hitoshi Ishikawa, et al.
International Journal of Radiation Oncology, Biology, Physics|September 19, 2006
Risk factors of late rectal bleeding after carbon ion therapy for prostate cancerHitoshi Ishikawa, Hiroshi Tsuji, Tadashi Kamada, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 25, 2019
Concurrent chemoradiotherapy using proton beams for unresectable locally advanced pancreatic cancerYuichi Hiroshima, Nobuyoshi Fukumitsu, Takashi Saito, et al.
Cancer Biology & Therapy|June 22, 2007
The radiation-induced cell-death signaling pathway is activated by concurrent use of cisplatin in sequential biopsy specimens from patients with cervical cancerMayumi Iwakawa, Tatsuya Ohno, Kaori Imadome, et al.
Japanese Journal of Radiology|July 8, 2018
Normal liver tissue change after proton beam therapyNobuyoshi Fukumitsu, Shinsei Takahashi, Toshiyuki Okumura, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 15, 2006
Carbon ion radiation therapy for prostate cancer: results of a prospective phase II studyHitoshi Ishikawa, Hiroshi Tsuji, Tadashi Kamada, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|June 13, 2022
Carbon-ion radiotherapy for urological cancersHitoshi Ishikawa, Yuichi Hiroshima, Nobuyuki Kanematsu, et al.
Pageof 41